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In the last few years there has been an increasing interest in nanomedicine and 
in particular in developing nanoparticles to fight cancer [1]. 
Zinc oxide nanocrystals (ZnO NCs), thanks to their peculiar properties, can be 
employed for cancer diagnosis and therapy. Even if the cytotoxicity mechanism 
of ZnO NCs is not totally understood yet, it is most probably due to the 
combination of intracellular Zn2+ cations release and the production of reactive 
oxygen species: in vitro tests have also shown an increased cytotoxic effect of 
ZnO on cancer cells with respect to the healthy counterpart [1]. 
In order to promote the stability of ZnO NCs in physiological environment, 
increase their biocompatibility and reduce their immunogenic effects, we covered 
ZnO NCs with a biomimetic phospholipidic bilayer [2] derived from extracellular 
vesicles, in particular exosomes, obtaining a nanoconstruct called 
TrojaNanoHorse (TNH). 
Exosomes are naturally produced by many types of cells as vehicle of 
intercellular communication and, when autologous, they are not recognized by 
the immune system. We extracted exosomes from living cells and we re-used 
them as a biomimetic, nature-derived coating to stabilize and reduce the 
immunogenicity of the ZnO NCs. Most importantly, we would like to exploit the 
natural communication function of exosome to drive the therapeutic 
nanoparticles towards the cancer cells [3].   
We optimized the coupling process between ZnO NCs and exosomes through a 
systematic study of the thermodynamic, kinetic and electrostatic parameters of 
the process and then we tested the efficiency of coupling by combining different 
characterization techniques. 
These experiments on the TNH preparation are the starting points to further 
study the TNH internalization process, mechanisms of causing cell damages, 
stability in biological fluids, and targeting mechanisms, to make TNH a new 
theranostic nanoconstruct against cancer.  
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